Can a tiny implant fix a leaky heart valve without open surgery?

NCT ID NCT04679714

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial is testing a new device called the PLAR Implant, which is designed to treat severe functional mitral regurgitation—a condition where the heart's mitral valve doesn't close properly, causing blood to leak backward. The implant is placed via a catheter through a vein in the leg, avoiding open-heart surgery. The study will enroll up to 10 patients at high surgical risk and will follow them for 5 years to assess safety, feasibility, and how well the device works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PLAR Implant and Delivery System (transcatheter mitral valve repair device)
What this could lead to
If successful, this device could offer a less invasive treatment option for people with severe functional mitral regurgitation who are at high risk for surgery.
What could go wrong
This is an early, small study (up to 10 patients) focused on safety and feasibility, so results may not be conclusive. Risks include procedural complications and the device may not effectively reduce regurgitation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL MITRAL REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • InCor - Instituto do Coração do Hospital das Clínicas da FMUSP

    São Paulo, São Paulo, 05403-900, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.